
Politics
Can FDAs New National Priority Voucher Meet Its Ambitious Goals?
The FDA’s CNPV program seeks to accelerate the review of drugs to drive U.S. public health goals with five priorities: addressing health crises, delivering innovative cures, covering unmet medical needs, strengthening local supply chains, and increasing affordability. Expedited drug review motivates development, but its ability to foster local production and affordability is questionable.
